Yesterday
Bellevue Gold set to raise equity; Macquarie, Canaccord on ticket
The deal is expected to launch as early as this week, sources said.
Eildon Capital on former boss’ M&A radar
Street Talk understands that Brisbane-based property fund manager and financier Trilogy Funds is weighing an acquisition of Eildon Capital.
Global beef players line up for Australian Meat Group
Street Talk understands Brazilian giants Minerva Foods and Marfrig, and China linked Silver Fern Farms and New Hope are getting their ducks in a row.
UBS, Centuria Bass Credit team up for inaugural warehouse facility
The Swiss investment bank has put up an initial $100 million senior secured commitment as it increases its exposure to Australia’s non-bank real estate lending sector.
Three banks mandated for Fonterra’s Australia sale
Sources said JPMorgan and Kiwi investment bank Cameron Partners, which have a strategic tie-up, have been mandated to run the sale alongside long-time adviser Jarden.
Au revoir! Vinci out at Queensland Airports auction as bids land
It’s the second time that Vinci, an investor in London’s Gatwick, Osaka’s Itami, Santiago and Lisbon, has missed out on adding an Aussie airport to its portfolio.
Antipodes Partners to acquire rival fund manager Maple-Brown Abbott
The nine-year-old Antipodes would oversee $18.6 billion in assets after the acquisition.
Rinehart-backed Arafura launches equity raise
Fund manager sources were told to expect a deal size in the order of $20 million, a sliver of the $US793 million that the company has flagged it would need.
Telix upsizes convertibles deal to $650m; delta block clears at $18.70
The pharmaceuticals company joins Xero and New Hope, which raised $1.27 billion and $300 million respectively in June via convertibles.
Revealed: Square Peg’s jealously guarded returns are here
Canva’s $US2.4 billion secondary share sale couldn’t have come at a better time for one of its backers – and just as it’s about to raise a new fund.
This Month
NZ’s Crimson Education retains unicorn status after stealth round
Street Talk understands investors in education technology, which is backed by former NZ prime minister John Key, have boosted their valuations after a funding round.
Crescent Capital’s 1¢ Pacific Smiles bid increase leads to chagrin
The skinny increase, which Crescent declared was their best and highest, sees the scheme consideration increase by 0.5 per cent to $1.91.
JPMorgan shops $226m delta placement block for Telix notes deal
Terms sent to potential investors show Telix shares were being offered under a variable price book build at $18.60 a share to $19.60.
Bin way too long! Affinity Equity hires bank for Waste Services sale
You’d be forgiven for thinking Affinity has a leg-up in the UBS-run auction, given its ANZ boss’s history with the asset.
Arc Energy sees plenty of PE cash – and it wants its share
The embedded network business has met with potential investors over the years, but has recently renewed its deal-making efforts.
Haben raising $263m to bankroll QIC’s Westpoint shopping centre buy
Potential investors have been told to expect 6.6 per cent in average annual distributions which would be paid quarterly, and at least 17 per cent pre-tax IRR.
Quadrant’s erstwhile top dealmaker returns armed with Packer cash
It’s taken a very sweet opportunity to bring him back to dealmaking – namely Everest Ice Cream, a major manufacturer of wholesale frozen desserts.
Crescent tries to pull off the near impossible at Pacific Smiles
But the private equity firm has another ace up its sleeve. Influential proxy adviser Institutional Shareholder Services has thrown its support behind the bid.
Heart medtech Anteris Technologies in $40m raise
The proceeds would fund development of its flagship DurAVR THV product which aims to mimic a healthy aortic valve.
Nasal viagra biotech launches capital raising, Alpine on ticket
Street Talk understands sole lead manager Alpine Capital was seeking bids at 73¢ per share on Monday morning.
